From Edge:
The only thing that hasn’t been engineered are the living things, ourselves. Again, what’s the consequence of doing that at scale? Biotechnology is 30 years old; it’s a young adult. Most of the work is still to come, but how do we actually do it? Let’s not talk about it, let’s actually go do it, and then let’s deal with the consequences in terms of how this is going to change ourselves, how the biosecurity framework needs to recognize that it’s not going to be nation-state driven work necessarily, how an ownership sharing and innovation framework needs to be developed that moves beyond patent-based intellectual property and recognizes that the information defining the genetic material’s going to be more important than the stuff itself and so you might transition away from patents to copyright and so on and so forth.
DREW ENDY, is Assistant Professor of Biological Engineering at MIT, where he is working to enable the design and construction of large scale integrated biological systems, and to develop and improve general methods for representing cellular behavior.
More here.
